These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding. Lins RD; Straatsma TP; Briggs JM Biopolymers; 2000 Apr; 53(4):308-15. PubMed ID: 10685051 [TBL] [Abstract][Full Text] [Related]
3. Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants. Lee MC; Deng J; Briggs JM; Duan Y Biophys J; 2005 May; 88(5):3133-46. PubMed ID: 15731379 [TBL] [Abstract][Full Text] [Related]
4. Reduced HIV-1 integrase flexibility as a mechanism for raltegravir resistance. Dewdney TG; Wang Y; Kovari IA; Reiter SJ; Kovari LC J Struct Biol; 2013 Nov; 184(2):245-50. PubMed ID: 23891838 [TBL] [Abstract][Full Text] [Related]
5. Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase. Yang ZN; Mueser TC; Bushman FD; Hyde CC J Mol Biol; 2000 Feb; 296(2):535-48. PubMed ID: 10669607 [TBL] [Abstract][Full Text] [Related]
6. The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study. Balasubramanian S; Rajagopalan M; Bojja RS; Skalka AM; Andrake MD; Ramaswamy A J Biomol Struct Dyn; 2017 Dec; 35(16):3469-3485. PubMed ID: 27835934 [TBL] [Abstract][Full Text] [Related]
7. Crystal structures of catalytic core domains of retroviral integrases and role of divalent cations in enzymatic activity. Wlodawer A Adv Virus Res; 1999; 52():335-50. PubMed ID: 10384241 [TBL] [Abstract][Full Text] [Related]
8. Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain. Molteni V; Greenwald J; Rhodes D; Hwang Y; Kwiatkowski W; Bushman FD; Siegel JS; Choe S Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):536-44. PubMed ID: 11264582 [TBL] [Abstract][Full Text] [Related]
9. The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant. Bujacz G; Alexandratos J; Qing ZL; Clément-Mella C; Wlodawer A FEBS Lett; 1996 Dec; 398(2-3):175-8. PubMed ID: 8977101 [TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Chen JC; Krucinski J; Miercke LJ; Finer-Moore JS; Tang AH; Leavitt AD; Stroud RM Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8233-8. PubMed ID: 10890912 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 integrase: the next target for AIDS therapy? d'Angelo J; Mouscadet JF; Desmaële D; Zouhiri F; Leh H Pathol Biol (Paris); 2001 Apr; 49(3):237-46. PubMed ID: 11367559 [TBL] [Abstract][Full Text] [Related]
12. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors. Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342 [TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance. Barreca ML; Lee KW; Chimirri A; Briggs JM Biophys J; 2003 Mar; 84(3):1450-63. PubMed ID: 12609852 [TBL] [Abstract][Full Text] [Related]
14. Structural determinants of metal-induced conformational changes in HIV-1 integrase. Asante-Appiah E; Seeholzer SH; Skalka AM J Biol Chem; 1998 Dec; 273(52):35078-87. PubMed ID: 9857042 [TBL] [Abstract][Full Text] [Related]
15. Novel HIV integrase inhibitors with anti-HIV activity: insights into integrase inhibition from docking studies. Cox AG; Nair V Antivir Chem Chemother; 2006; 17(6):343-53. PubMed ID: 17249248 [TBL] [Abstract][Full Text] [Related]
16. High-resolution structure of the catalytic domain of avian sarcoma virus integrase. Bujacz G; Jaskólski M; Alexandratos J; Wlodawer A; Merkel G; Katz RA; Skalka AM J Mol Biol; 1995 Oct; 253(2):333-46. PubMed ID: 7563093 [TBL] [Abstract][Full Text] [Related]
17. Constructing HIV-1 integrase tetramer and exploring influences of metal ions on forming integrase-DNA complex. Wang LD; Liu CL; Chen WZ; Wang CX Biochem Biophys Res Commun; 2005 Nov; 337(1):313-9. PubMed ID: 16188234 [TBL] [Abstract][Full Text] [Related]
18. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform. Chen Z; Yan Y; Munshi S; Li Y; Zugay-Murphy J; Xu B; Witmer M; Felock P; Wolfe A; Sardana V; Emini EA; Hazuda D; Kuo LC J Mol Biol; 2000 Feb; 296(2):521-33. PubMed ID: 10669606 [TBL] [Abstract][Full Text] [Related]
19. The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Bujacz G; Jaskólski M; Alexandratos J; Wlodawer A; Merkel G; Katz RA; Skalka AM Structure; 1996 Jan; 4(1):89-96. PubMed ID: 8805516 [TBL] [Abstract][Full Text] [Related]
20. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Goldgur Y; Dyda F; Hickman AB; Jenkins TM; Craigie R; Davies DR Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9150-4. PubMed ID: 9689049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]